Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Daniel S. Goldberger | Chief Executive Officer | 2025-03-17 | 1,000 | $8.59 | $8.59kBuy |
Thomas J. Errico | Director | 2025-03-17 | 6,000 | $8.10 | $48.59kBuy |
Thomas J. Errico | Director | 2024-08-15 | 5,000 | $6.12 | $30.60kBuy |
John P. Gandolfo | Director | 2024-06-13 | 1,000 | $6.43 | $6.43kBuy |
Thomas J. Errico | Director | 2024-06-05 | 38,505 | $6.43 | $247.59kBuy |
Patricia Wilber | Director | 2024-06-05 | 6,931 | $6.43 | $44.57kBuy |
Daniel S. Goldberger | Chief Executive Officer | 2024-06-05 | 38,505 | $6.43 | $247.59kBuy |
Julie Ann Goldstein | Director | 2024-06-05 | 7,701 | $6.43 | $49.52kBuy |
Thomas M. Patton | Director | 2024-06-05 | 7,701 | $6.43 | $49.52kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Joseph P. Errico | 53.69% | 3,861,942 | $23.25M | Insider |
Merck Global Health Innovation Fund LLC | 46.52% | 3,346,032 | $20.14M | Insider |
James L. L. Tullis | 28.00% | 2,014,110 | $12.12M | Insider |
Thomas J. Errico | 13.37% | 961,491 | $5.79M | Insider |
Core Ventures II LLC | 8.99% | 646,342 | $3.89M | Insider |
Peter S. Staats | 6.62% | 476,419 | $2.87M | Insider |
Charles Steve Theofilos | 6.43% | 462,758 | $2.79M | Insider |
Francis R. Amato | 5.12% | 368,355 | $2.22M | Insider |
Daniel S. Goldberger | 4.04% | 290,565 | $1.75M | Insider |
Vanguard Group Inc | 2.35% | 168,924 | $1.02M | Institution |